Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
9-ING-41 in Patients With Advanced CancersNCT03678883ACTUPhase 2Active not recruiting2026-06Estimated
Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact DermatitisNCT03680131EDSAPhase 2Completed2022-09-21Actual
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal HyperplasiaNCT03687242Spruce BiosciencesPhase 2Completed2019-07-08Actual
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted TherapyNCT03690388ExelixisPhase 3Active not recruiting2020-08-19Actual
A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent ThalassemiaNCT03692052AGIOPhase 2Active not recruiting2020-08-20Actual
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing SyndromeNCT03697109Corcept TherapeuticsPhase 3Completed2024-04-08Actual
A Study of OV101 in Individuals With Fragile X SyndromeNCT03697161OVIDPhase 2Completed2020-02-03Actual
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)NCT03703310SLGLPhase 3Completed2020-12-28Actual
Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to TherapyNCT03719690KURAPhase 2Completed2023-05-02Actual
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)NCT03721978Inovio PharmaceuticalsPhase 3Completed2022-08-23Actual
Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent PericarditisNCT03737110Kiniksa Pharmaceuticals (UK), Ltd.Phase 3Completed2020-05-29Actual
APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)NCT03745716Aprea TherapeuticsPhase 3Completed2020-11-27Actual
Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe ObesityNCT03746522RYTMPhase 3Completed2020-11-16Actual
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer TherapyNCT03755791ExelixisPhase 3Active not recruiting2021-11-30Actual
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative ColitisNCT03760003ABVXPhase 2Completed2021-04-01Actual
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA NephropathyNCT03762850TVTXPhase 3Active not recruiting2023-08-07Actual
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)NCT03767348Replimune, Inc.Phase 2Active not recruiting2028-06Estimated
Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion SicknessNCT03772340Vanda PharmaceuticalsPhase 2Completed2019-06-06Actual
Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT03776812Corcept TherapeuticsPhase 2Completed2021-03-16Actual
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal EpilepsyNCT03796962XENEPhase 2Active not recruiting2021-09-02Actual
Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MSNCT03799718Brainstorm-Cell TherapeuticsPhase 2Completed2021-03-11Actual
Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V)NCT03801525TGTXPhase 2, Phase 3Terminated2022-12-20Actual
GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)NCT03815825IONSPhase 2Completed2024-04-18Actual
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic MedicationsNCT03818256Corcept TherapeuticsPhase 2Completed2022-06-17Actual
KPL-301 for Subjects With Giant Cell ArteritisNCT03827018Kiniksa Pharmaceuticals, Ltd.Phase 2Completed2020-08-13Actual
Study to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular LymphomaNCT03828448TGTXPhase 2Terminated2022-05-16Actual
rVA576 (Coversin) Long Term Safety and Efficacy Surveillance StudyNCT03829449AKARI TherapeuticsPhase 3Terminated2020-08-29Actual
A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)NCT03834753OTLKPhase 3Completed2021-06-07Actual
A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSDNCT03841773Tonix Pharmaceuticals, Inc.Phase 3Terminated2020-04-24Actual
A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)NCT03844074OTLKPhase 3Completed2020-07-23Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.